This afternoon, DHI issued a press release announcing its financial results for the fourth quarter and year-end 2025. Please ...

Multiple myeloma (MM) is a genetically complex and heterogenous malignancy with a 5-year survival rate of approximately 60%. Patients experience periods of relapse and remission, with prognosis ...